http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111533795-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111533795-B |
| titleOfInvention | HLA-A2 restricted bladder cancer tumor neoantigen peptide sequence and application thereof |
| abstract | The invention discloses an HLA-A2 restricted bladder cancer tumor neoantigen peptide sequence, which is selected from any one or any combination of antigen sequences of the following 12 genes: CDKN1A gene, RHOB gene, CDC42 gene, DDB1 gene, AHNAK gene, ANP32A gene, ALDH16A1 gene, MET gene, PRDX6 gene, MKI67 gene, GAK gene and DSG3 gene, and the antigen sequences are respectively shown in SEQ ID NO. 1-12. In addition, the invention discloses application of the antigen sequence in preparation of a bladder cancer diagnostic reagent and a bladder cancer treatment drug. |
| priorityDate | 2019-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.